PUMA BIOTECHNOLOGY, INC. - 10-Q Filing
Puma Biotechnology filed its Q1 2026 Form 10-Q with the SEC on May 4, 2026. The filing includes financial data for the quarter ended March 31, 2026, and provides details about operating segments such as clinical research, medical affairs, and other R&D activities.
Tickers: $PBYI